Skip to main content
. 2023 Jul 4;2023:6615624. doi: 10.1155/2023/6615624

Table 2.

Medication regimens.

Medication regimen, N (%) Total DKA EuDKA hDKA
SGLT2i only 0 (0%) 0 (0%) 0 (0%)
SGLT2i + metformin 1 (3.45%) 0 (0%) 1 (6.7%)
SGLT2i + thiazolidinedione 1 (3.45%) 1 (7.1%) 0 (0%)
SGLT2i + GLP1 agonist 1 (3.45%) 1 (7.1%) 0 (0%)
SGLT2i + sulfonylurea 1 (3.45%) 0 (0%) 1 (6.7%)
SGLT2i + 2 agents 10 (34.5%) 5 (35.7%) 5 (33.3%)
SGLT2i + ≥3 agents 4 (13.8%) 3 (21.5%) 1 (6.7%)
SGLT2i + insulin ± other agents 11 (37.9%) 4 (28.6%) 7 (46.6%)